Millennium Management
CGEM icon

Millennium Management’s Cullinan Oncology CGEM Stock Holding History

Millennium Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
+20,000
New +$257K ﹤0.01% 5029

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Millennium Management's CGEM Position: Q1 2026 in Review

Millennium Management reduced its Cullinan Oncology (CGEM) stake by 4.4% in Q1 2026, selling an estimated $205K and leaving 346,582 shares worth $4.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

Millennium Management first reported a position in CGEM in Q1 2021 and has held it in 18 quarters since. The position peaked at $16.8M in Q1 2021. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Millennium Management held 346,582 shares of Cullinan Oncology worth $4.92M as of Q1 2026.
  • Millennium Management sold 15,913 Cullinan Oncology shares in Q1 2026, an estimated $205K.
  • Cullinan Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2962 holding.
  • Millennium Management first reported a position in Cullinan Oncology in Q1 2021 and has held it in 18 quarters since.
  • Millennium Management's Cullinan Oncology position peaked at $16.8M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.